Keyphrases
Acute Ischemic Stroke
25%
Alberta Stroke Programme Early CT Score (ASPECTS)
13%
Amnestic Syndrome
9%
Anterior Circulation
32%
Anterograde Amnesia
9%
Area under the Curve
9%
Basal Ganglia Hemorrhage
9%
Blood Pressure
18%
Carotid Web
9%
Cerebral Angiography
9%
Chronic Kidney Disease
9%
Clinical Outcomes
14%
Confabulation
9%
Confidence Interval
10%
Contrast-induced Nephropathy
9%
Decision Algorithm
9%
DEFUSE 3
9%
Diabetic
11%
Diffusion-weighted Imaging
9%
Endovascular Stroke Treatment
24%
Endovascular Therapy
32%
Final Infarct Volume
12%
Home-based
9%
Hyperglycemia
9%
Infarct Volume
16%
Ischemic Stroke
35%
Large Vessel Occlusion
37%
Large Vessel Occlusion Stroke
21%
Malignant Cerebral Infarction
9%
Meta-analysis
9%
Modified Rankin Scale
18%
Multidisciplinary Rehabilitation
9%
Outcome Prediction
12%
Parietal Operculum
9%
Pathophysiology
12%
Patient Selection
9%
Perfusion Imaging
13%
Perihematomal Edema Volume
9%
Pittsburgh
18%
Poor Outcome
13%
Post-optimization
9%
Pre-optimization
9%
Recanalization
9%
Subgroup Analysis
13%
Sulfonylurea
9%
Symptomatic Intracerebral Hemorrhage (sICH)
9%
Systolic Blood Pressure
9%
Thrombectomy
15%
Training Therapy
9%
Vascular Neurosurgery
9%
Medicine and Dentistry
Air Embolism
9%
Anterograde Amnesia
5%
Apoplexy
100%
Basal Ganglion Hemorrhage
9%
Blood Pressure
18%
Brain Ischemia
43%
Case-Control Study
9%
Cerebral Angiography
9%
Cerebral Hemorrhage
22%
Chronic Kidney Disease
9%
Cohort Effect
9%
Confabulation
5%
Contrast-Induced Nephropathy
9%
Diagnosis
6%
Diffusion MRI
6%
Edema
9%
Endovascular Surgery
32%
Esophagogastroduodenoscopy
9%
Finger
6%
Health Care Cost
12%
Infarction
21%
Large Vessel Occlusion
54%
Modified Rankin Scale
13%
National Institutes of Health Stroke Scale
6%
Odds Ratio
7%
Pathophysiology
10%
Patient Selection
9%
Placebo
7%
Prospective Cohort Study
18%
Pulmonary Arteriovenous Fistula
9%
Recanalization
12%
Scintigraphy
13%
Spine Surgery
9%
Stroke Therapy
25%
Subgroup Analysis
13%
Sulfonylurea
9%
Systematic Review
10%
Systolic Blood Pressure
9%
Telerehabilitation
6%
Tenecteplase
9%
Thrombectomy
24%
Tissue Plasminogen Activator
5%
Transcranial Direct Current Stimulation
9%